Dr. Michael Katzberg did his PhD studies in the field of biotechnological production of pharmaceutical chiral intermediates and received his PhD from the Technical University Dresden, Germany after a short term stay at Lunds University, Sweden in 2009. Before joining thyssenkrupp he worked as a biotech group leader at University of Mining and Technology Freiberg, Germany. His fields of study were mainly second generation biofuels as well as process development for biotechnologically produced chiral intermediates. He Joined thyssenkrupp in Leuna in 2012 with the start-up of the biotech demo plant there and since then is heading the laboratory and small pilot plant, in which development of thyssenkrupps own biotech processes and projects of most of its customers started (tech transfer, scale-up studies) before they were scaled-up to the demo plant scale.